BDBM306490 (+-)-N-[(6-amino-4-methoxy-2- methylpyridin-3-yl)methyl]- 12-[(4-methyl-1H-pyrazol-1-yl)- methyl]-15- oxatetracyclo[6.6.1.02,7.09,14]- pentadeca-2,4,6,9,11,13- hexaene-4-carboxamide::US10144746, Compound 132

SMILES COc1cc(N)nc(C)c1CNC(=O)c1ccc2C3OC(c4cc(Cn5cc(C)cn5)ccc34)c2c1

InChI Key InChIKey=VGSWGVNTDAOLTK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 306490   

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandPNGBDBM306490((+-)-N-[(6-amino-4-methoxy-2- methylpyridin-3-yl)m...)
Affinity DataIC50: 2nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
Go to US Patent